SARA PENCE: Open Payments
NPI 1386051068 · SOMERSET, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$801 in 45 payments from 7 companies in 2025. Trend: 2023 $106 · 2024 $494 · 2025 $801
Food & beverage: $801
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 16 | $273 |
| ABBVIE INC. | 19 | $272 |
| AstraZeneca Pharmaceuticals LP | 1 | $84 |
| Otsuka America Pharmaceutical, Inc. | 4 | $73 |
| Biogen, Inc. | 2 | $49 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $36 |
| Alkermes, Inc. | 1 | $14 |
Products named: FANAPT, VRAYLAR, UBRELVY, AIRSUPRA, REXULTI, ZURZUVAE, QULIPTA, CAPLYTA.
Industry payments across KY — which companies pay providers there.
